Engelhart James

Insider profile

Engelhart James's trades of Biohaven Pharmaceutical Holding Company Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2021-12-10 2021-12-10 PlS Planned sale
51,239 -33.8%
276.60
US$2,484,084
51,239 -33.8% 276.60 US$2,484,084
2021-12-10 2021-12-10 PlS Planned sale
10,857 +17.4%
383.60
US$3,136,123
10,857 +17.4% 383.60 US$3,136,123
2021-12-10 2021-12-10 PlS Planned sale
57,651 -49.5%
241.63
US$3,303,324
57,651 -49.5% 241.63 US$3,303,324
2020-06-12 2020-06-11 PlS Planned sale
2,452 -35.2%
64.85
US$159,015
2,452 -35.2% 64.85 US$159,015
2020-06-12 2020-06-11 PlS Planned sale
6,501 -48.2%
64.31
US$418,058
6,501 -48.2% 64.31 US$418,058
2020-06-12 2020-06-11 PlS Planned sale
4,847 -26.5%
63.19
US$306,286
4,847 -26.5% 63.19 US$306,286
2020-06-12 2020-06-11 PlS Planned sale
5,972 -24.6%
62.07
US$370,698
5,972 -24.6% 62.07 US$370,698
2020-06-12 2020-06-10 PlS Planned sale
300 -6.2%
68.07
US$20,420
300 -6.2% 68.07 US$20,420
2020-06-12 2020-06-10 PlS Planned sale
24,832 -83.7%
67.53
US$1,676,989
24,832 -83.7% 67.53 US$1,676,989
2020-06-12 2020-06-10 PlS Planned sale
28,821 -49.3%
66.66
US$1,921,136
28,821 -49.3% 66.66 US$1,921,136
2019-06-28 2019-06-27 B Purchase
2,500 +inf%
43.05
US$107,625
2,500 +inf% 43.05 US$107,625